Inovie, Biotech Stock Review

Shorts Set $1.00 Price Target on Inovio (INO) $9.20.

Interesting battle brewing! LIVE CHART Inovio shares tumble 8% after short seller Muddy Waters says don't believe the COVID-19 vaccine hype (MarketWatch). Inovio Pharmaceuticals Inc. shares INO, -6.19% slid...

Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in...

American Chemical Society May 2020. Higher rates of serious illness and death from coronavirus SARS-CoV-2 (COVID-19) infection among older people and those who have comorbidities...

‘Amazing potential.’ UM doctor to start stem cell trial for coronavirus patients (Miami Herald)

BY BEN CONARCK APRIL 16, 2020 A team of doctors at the University of Miami won emergency federal approval to use stem cell therapy on...
Fletcher Robbe

Dalrada (DFCO) Legal Counsel

CONTINUOUSLY UPDATED Dalrada Financial Adds Robbe to Board of DirectorsDalrada Financial Corporation Hires Fletcher Robbe International Dalrada Financial Adds Robbe to Board of Directors HENDERSON, Nev., Aug....

Latest article

Sekur Private Data (SWISF) Awarded Distribution Agreement With Elyon International.

Top Ranked Defense, Government and Enterprise Contractor Trying to Break Over $0.06. We are still sitting on the edge of our seat waiting for contract news,...

Broker Dealer – AtlasClear (ATCH) Conference Call

"AtlasClear is being built as an integrated financial services platform that will bring capital markets origination, clearing, and banking together under a single architecture."...